Taconic Biosciences Expands Scientific Advisory Board
Dr. Monica Gostissa Joins Taconic Biosciences’ Scientific Advisory Board
RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD.
The SAB collaborates with Taconic management, providing scientific insight and guidance to expand the company’s product and service portfolio. Dr. Gostissa’s extensive career in the immunology and immuno-oncology fields brings new expertise to the board and complements Taconic’s leadership in these research areas.
Dr. Monica Gostissa Joins Taconic Biosciences’ Scientific Advisory Board
RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD.
The SAB collaborates with Taconic management, providing scientific insight and guidance to expand the company’s product and service portfolio. Dr. Gostissa s extensive career in the immunology and immuno-oncology fields brings new expertise to the board and complements Taconic’s leadership in these research areas.